Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Epidemiological characteristics and genotype distribution of human papillomavirus infection among 39,335 women in Gaochun District, Nanjing, China
Zhili Zhou; Ping Wang; Jieling Zhang; Li ZhangShow moreShow less
1. Department of Obstetrics and Gynecology, Gaochun People’s Hospital of Nanjing, Nanjing, China; 2. Department of Obstetrics and Gynecology, Affiliated Gaochun People’s Hospital of Jiangsu Health Vocational College, Nanjing, China; 3. Department of Radiation Oncology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Affiliated Central Hospital of Huzhou University, Huzhou, ChinaShow moreShow less
The microbiome–cancer axis: microbial biomarkers across gastrointestinal malignancies
Shahrzad Asgari; Parastoo SanieeShow moreShow less
1. Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, IranShow moreShow less
Genome-wide association study of human papillomavirus infection and persistence in women living with HIV in Rwanda
Åsa Torinsson Naluai; Schifra Uwamungu; Maria Andersson; Bethelehem Nigussie Zewdie; Claude Mambo Muvunyi; Emile Bienvenu; Bengt Hasséus; Daniel GiglioShow moreShow less
1. Department of Laboratory Medicine, Institute of Biomedicine and Core Facilities, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 2. Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 3. Department of Biomedical Laboratory Sciences, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda; 4. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5. Communicable and Non-communicable Diseases Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia; 6. Department of Clinical Biology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda; 7. Rwanda Biomedical Centre, Kigali, Rwanda; 8. Rwanda Food and Drugs Authority, Kigali, Rwanda; 9. Department of Pharmacy, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda; 10. Department of Oral Medicine and Pathology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 11. Department of Medicine and Oncology, Southern Älvsborg Hospital, Borås, Sweden; 12. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenShow moreShow less
Sampling constraints, sparse-cell estimates, and cross-sectional inference: considerations on hr-HPV prevalence and associated factors among HIV-positive women in Mekelle, Ethiopia
Shweta ThusooShow moreShow less
1. Dr. D. Y. School of Allied Health Sciences, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, IndiaShow moreShow less
HPV knowledge, awareness, and vaccine beliefs among women attending gynecological care in Türkiye: implications for cervical cancer prevention
Figen Efe Camili; Sevde AksuShow moreShow less
1. Faculty of Medicine, Department of Obstetrics and Gynecology, Balıkesir University, Balıkesir, Türkiye; 2. Faculty of Health Sciences, Department of Nursing, Balikesir University, Balikesir, TürkiyeShow moreShow less
Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings
Michel Carlos Tommo Tchouaket; Jeremiah Efakika Gabisa; Ezechiel Ngoufack Jagni Semengue; Larissa Gaelle Moko Fotso; Valentine Marie Ferré; Bernadette Fokou Bomgning; Keriane Diane Kambou Kountchou; Alex Durand Nka; Nadine Nguendjoung Fainguem; Yagai Bouba; Désiré Takou; Rachel Kamgaing; Aude Christelle Ka’e; Collins Ambe Chenwi; Samuel Martin Sosso; Charlotte Charpentier; Carlo-Federico Perno; Vittorio Colizzi; Fon Wilfred Mbacham; Joseph Fokam; Alexis NdjoloShow moreShow less
1. Chantal BIYA International Reference Centre, for Research on HIV/AIDS Prevention and Management, Yaounde, Cameroon; 2. Fobang Institute for Innovations in Science and Technology, Yaounde, Cameroon; 3. Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon; 4. Université de Paris, IAME, INSERM, Paris, France; 5. AP-HP, Hopital Bichat, DEBRC, Paris, France; 6. Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy; 7. UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy; 8. Bambino Gesù Children Hospital, IRCCS, Rome, Italy; 9. Faculty of Medicine, “Good Samaritan” Teaching Hospital, N’Djamena, Chad; 10. Central Technical Group, National AIDS Control Committee (NACC), Ministry of Public Health, Yaounde, CameroonShow moreShow less
FAQ
How long does Infectious Agents and Cancer take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for Infectious Agents and Cancer. The fastest paper went from submission to acceptance in 47 days (Point-of-care hrHPV mRNA detection with reverse transcription recombinase polymerase amplification on a portable fluorimeter from provider-collected cervical samples in Maputo, Mozambique, received 2026-04-25, accepted 2026-06-11); the slowest took 234 days. The average is 96.7 days and the median is 84 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
